Fibrinogen and associated risk factors in a high-risk population: Urban indigenous australians, the druid Study

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Maple Brown, Louise J ^a,b   Cunningham, Joan ^a   Nandi, Nirjhar ^b   Hodge, Allison ^c   O'Dea, Kerin ^d  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID;

ADOLESCENT; ADULT; AGE; ALCOHOL ABSTINENCE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; FACTORIAL ANALYSIS; FEMALE; GENDER; GROUPS BY AGE; HEART RATE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; URINALYSIS; URINE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGE DISTRIBUTION; AGED; AUSTRALIA; BLOOD; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; ETHNIC AND RACIAL GROUPS; ETHNOLOGY; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; STATISTICS; UPREGULATION; URBAN POPULATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; NORTHERN TERRITORY; POPULATION GROUPS; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SMOKING; UP-REGULATION; URBAN POPULATION; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 77958597575     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-69     Document Type: Article

References (23)

1. Heart, stroke and vascular disease: Australian facts 2004. Cardiovascular Disease Series, No. 22. 2004, Canberra: Australian Institute of Health and Welfare and National Heart Foundation of Australia.
2. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005, 294(14):1799-1809. 10.1001/jama.294.14.1799, 16219884.
3. Kaptoge S, White IR, Thompson SG, Wood AM, Lewington S, Lowe GD, Danesh J. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007, 166(8):867-879. 10.1093/aje/kwm191, 17785713.
4. Sakakibara H, Fujii C, Naito M. Plasma fibrinogen and its association with cardiovascular risk factors in apparently healthy Japanese subjects. Heart Vessels 2004, 19(3):144-148. 10.1007/s00380-003-0753-5, 15168063.
5. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PF, Muller JE, D'Agostino RB. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000, 102(14):1634-1638.
6. Palmieri V, Celentano A, Roman MJ, de Simone G, Best L, Lewis MR, Robbins DC, Fabsitz RR, Howard BV, Devereux RB. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am Heart J 2003, 145(3):467-474. 10.1067/mhj.2003.144, 12660670.
7. Yan RT, Fernandes V, Yan AT, Cushman M, Redheuil A, Tracy R, Vogel-Claussen J, Bahrami H, Nasir K, Bluemke DA, et al. Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2010, 160(3):479-486. 10.1016/j.ahj.2010.06.001, 20826256.
8. Gupta AK, Cornelissen G, Greenway FL, Dhoopati V, Halberg F, Johnson WD. Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults. Cardiovasc Diabetol 2010, 9(1):58. 2955642, 20868493, 10.1186/1475-2840-9-58.
9. Brunner E, Davey G, Marmot M, Canner R, Beksinska M, O'Brien J. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 1996, 347(9007):1008-1013. 10.1016/S0140-6736(96)90147-6, 8606563.
10. Wang Z, Rowley K, Best J, McDermott R, Taylor M, O'Dea K. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations. Metabolism 2007, 56(5):629-635. 10.1016/j.metabol.2006.12.009, 17445537.
11. Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, Montague PA, Lonn E. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). The Lancet 2001, 358(9288):1147-1153.
12. Kizer JR, Krauser DG, Rodeheffer RJ, Burnett JC, Okin PM, Roman MJ, Umans JG, Best LG, Lee ET, Devereux RB. Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study). Am J Cardiol 2009, 104(2):247-253. 2745719, 19576355, 10.1016/j.amjcard.2009.03.026.
13. ABS & AIHW (Australian Bureau of Statistics & Australian Institute of Health and Welfare). The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples. 2005, Canberra.
14. Australian Bureau of Statistics. Population Distribution, Indigenous Australians. ABS cat. no. 4705.0. 2002, Canberra.
15. Cunningham J, O'Dea K, Dunbar T, Weeramanthri TS, Zimmet P, Shaw J. Study Protocol - Diabetes and related conditions in urban Indigenous people in the Darwin, Australia region: aims, methods and participation in the DRUID Study. BMC Public Health 2006, 6:8. 1373687, 16417641, 10.1186/1471-2458-6-8.
16. O'Dea K, Cunningham J, Maple-Brown L, Weeramanthri T, Shaw J, Dunbar T, Zimmet P. Diabetes and cardiovascular risk factors in urban Indigenous adults: Results from the DRUID study. Diabetes Res Clin Pract 2008, 80(3):483-489. 10.1016/j.diabres.2008.02.008, 18359533.
17. World Health Organisation. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. 1999, Geneva: Department of Noncommunicable Disease Surveillance, WHO.
18. Woodward M, Rumley A, Lowe GD, Tunstall-Pedoe H. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 2003, 122(1):135-141. 10.1046/j.1365-2141.2003.04387.x, 12823355.
19. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375(9709):132-140. 10.1016/S0140-6736(09)61717-7, 20031199.
20. Jax TW, Peters AJ, Plehn G, Schoebel FC. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients. Cardiovasc Diabetol 2009, 8:48. 2743654, 19735543, 10.1186/1475-2840-8-48.
21. Shemesh T, Rowley KG, Jenkins A, Brimblecombe J, Best JD, O'Dea K. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia. 2006, 31(1):103-108.
22. Hanley AJ, Festa A, D'Agostino RB, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 2004, 53(7):1773-1781. 10.2337/diabetes.53.7.1773, 15220201.
23. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000, 152(10):897-907. 10.1093/aje/152.10.897, 11092431.